2012•Psychiatry ResearchOpen access

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker

Warrick J. Brewer, Ashleigh Lin, Paul J. Moberg, Gregory Smutzer, Barnaby Nelson, Alison R. Yung, Christos Pantelis, Patrick D. McGorry, Bruce I. Turetsky, Stephen J. Wood

Open full text 11 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Endophenotype, Schizophrenia (object-oriented programming), Psychosis, Prodrome, Psychology, Family history, Clinical psychology, Schizotypy

Back to paper search Browse research topics Original source

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker — Research Paper | ScholarLens